Estrogen Receptor Alpha and Nuclear Factor Y Coordinately Regulate the Transcription of the SUMO-Conjugating UBC9 Gene in MCF-7 Breast Cancer Cells

Por Ying, Shibo, Dünnebier, Thomas, Si, Jing, Hamann, Ute
Publicado em 2013

The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutatio...

Por Jakubowska, Anna, Rozkrut, Dominik, Antoniou, Antonis, Hamann, Ute, Lubinski, Jan
Publicado em 2009

Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan

Por Rashid, Muhammad U, Muhammad, Noor, Faisal, Saima, Amin, Asim, Hamann, Ute
Publicado em 2013

Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families

Por Liu, Xuan, Sinn, Hans-Peter, Ulmer, Hans Ulrich, Scott, Rodney J, Hamann, Ute
Publicado no Hered Cancer Clin Pract (2004)

Practical investigation of the performance of robust logistic regression to predict the genetic risk of hypertension

Por Kesselmeier, Miriam, Legrand, Carine, Peil, Barbara, Kabisch, Maria, Fischer, Christine, Hamann, Ute, Lorenzo Bermejo, Justo
Publicado em 2014

Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study

Por Rashid, Muhammad Usman, Muzaffar, Merium, Khan, Faiz Ali, Kabisch, Maria, Muhammad, Noor, Faiz, Sabeen, Loya, Asif, Hamann, Ute
Publicado no PLoS One (2015)

A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome

Por Rashid, Muhammad U., Naeemi, Humaira, Muhammad, Noor, Loya, Asif, Yusuf, Muhammed A., Lubiński, Jan, Jakubowska, Anna, Hamann, Ute
Publicado no Hered Cancer Clin Pract (2016)

High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients

Por Rashid, Muhammad Usman, Muhammad, Noor, Bajwa, Seerat, Faisal, Saima, Tahseen, Muhammad, Bermejo, Justo Lorenzo, Amin, Asim, Loya, Asif, Hamann, Ute
Publicado no BMC Cancer (2016)

Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism

Por Jakubowska, Anna, Gronwald, Jacek, Menkiszak, Janusz, Górski, Bohdan, Huzarski, Tomasz, Byrski, Tomasz, Benner, Axel, Lubiński, Jan, Scott, Rodney J, Hamann, Ute
Publicado em 2008

The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor

Por Ashton, Katie A, Proietto, Anthony, Otton, Geoffrey, Symonds, Ian, McEvoy, Mark, Attia, John, Gilbert, Michael, Hamann, Ute, Scott, Rodney J
Publicado em 2008

Integrin β3 Leu33Pro polymorphism increases BRCA1‐associated ovarian cancer risk

Por Jakubowska, Anna, Gronwald, Jacek, Menkiszak, Janusz, Górski, Bohdan, Huzarski, Tomasz, Byrski, Tomasz, Edler, Lutz, Lubiński, Jan, Scott, Rodney J, Hamann, Ute
Publicado em 2007

Systematic Pathway Enrichment Analysis of a Genome-Wide Association Study on Breast Cancer Survival Reveals an Influence of Genes Involved in Cell Adhesion and Calcium Signaling on...

Por Woltmann, Andrea, Chen, Bowang, Lascorz, Jesús, Johansson, Robert, Eyfjörd, Jorunn E., Hamann, Ute, Manjer, Jonas, Enquist-Olsson, Kerstin, Henriksson, Roger, Herms, Stefan, Hoffmann, Per, Hemminki, Kari, Lenner, Per, Försti, Asta
Publicado em 2014

Inbreeding and homozygosity in breast cancer survival

Por Thomsen, Hauke, Filho, Miguel Inacio da Silva, Woltmann, Andrea, Johansson, Robert, Eyfjörd, Jorunn E., Hamann, Ute, Manjer, Jonas, Enquist-Olsson, Kerstin, Henriksson, Roger, Herms, Stefan, Hoffmann, Per, Chen, Bowang, Huhn, Stefanie, Hemminki, Kari, Lenner, Per, Försti, Asta
Publicado no Sci Rep (2015)

Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms

Por Ji, Yuan, Olson, Janet, Zhang, Jianping, Hildebrandt, Michelle, Wang, Liewei, Ingle, James, Fredericksen, Zachary, Sellers, Thomas, Miller, William R., Dixon, J. Michael, Brauch, Hiltrud, Eichelbaum, Michel, Justenhoven, Christina, Hamann, Ute, Ko, Yon, Brüning, Thomas, Chang-Claude, Jenny, Wang-Gohrke, Shan, Schaid, Daniel, Weinshilboum, Richard
Publicado em 2008

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

Por Schroth, Werner, Goetz, Matthew P., Hamann, Ute, Fasching, Peter A., Schmidt, Marcus, Winter, Stefan, Fritz, Peter, Simon, Wolfgang, Suman, Vera J., Ames, Matthew M., Safgren, Stephanie L., Kuffel, Mary J., Ulmer, Hans Ulrich, Boländer, Julia, Strick, Reiner, Beckmann, Matthias W., Koelbl, Heinz, Weinshilboum, Richard M., Ingle, James N., Eichelbaum, Michel, Schwab, Matthias, Brauch, Hiltrud
Publicado em 2009

Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls

Por Fletcher, Olivia, Johnson, Nichola, dos Santos Silva, Isabel, Kilpivaara, Outi, Aittomäki, Kristiina, Blomqvist, Carl, Nevanlinna, Heli, Wasielewski, Marijke, Meijers-Heijerboer, Hanne, Broeks, Annegien, Schmidt, Marjanka K., Van’t Veer, Laura J., Bremer, Michael, Dörk, Thilo, Chekmariova, Elena V., Sokolenko, Anna P., Imyanitov, Evgeny N., Hamann, Ute, Rashid, Muhammad U., Brauch, Hiltrud, Justenhoven, Christina, Ashworth, Alan, Peto, Julian
Publicado em 2009

CYP2B6*6 is associated with increased breast cancer risk

Por Justenhoven, Christina, Pentimalli, Daniela, Rabstein, Sylvia, Harth, Volker, Lotz, Anne, Pesch, Beate, Brüning, Thomas, Dörk, Thilo, Schürmann, Peter, Bogdanova, Natalia, Park-Simon, Tjoung-Won, Couch, Fergus J., Olson, Janet E., Fasching, Peter A, Beckmann, Matthias W., Häberle, Lothar, Ekici, Arif, Hall, Per, Czene, Kamilla, Liu, Janjun, Li, Jingmei, Baisch, Christian, Hamann, Ute, Ko, Yon-Dschun, Brauch, Hiltrud
Publicado em 2013

The UGT1A6_19_GG genotype is a breast cancer risk factor

Por Justenhoven, Christina, Obazee, Ofure, Winter, Stefan, Rabstein, Sylvia, Lotz, Anne, Harth, Volker, Pesch, Beate, Brüning, Thomas, Baisch, Christian, Hartikainen, Jaana M., Mannermaa, Arto, Kosma, Veli-Matti, Kataja, Vesa, Winqvist, Robert, Pylkäs, Katri, Jukkola-Vuorinen, Arja, Grip, Mervi, Fasching, Peter A., Beckmann, Matthias, Ekici, Arif B., Hein, Alexander, Hall, Per, Li, Jingmei, Chang-Claude, Jenny, Flesch-Janys, Dieter, Seibold, Petra, Rudolph, Anja, Hamann, Ute, Ko, Yon-Dschun, Brauch, Hiltrud
Publicado em 2013

An Evaluation of Genetic Heterogeneity in 145 Breast-Ovarian Cancer Families

Por Narod, Steven A., Ford, Deborah, Devilee, Peter, Barkardottir, Rosa B., Lynch, Henry T., Smith, Simon A., Ponder, Bruce A. J., Weber, Barbara L., Garber, Judy E., Birch, Jill M., Cornelis, Renee S., Kelsell, David P., Spurr, Nigel K., Smyth, Elizabeth, Haites, Neva, Sobol, Hagay, Bignon, Yves-Jean, Chang-Claude, Jenny, Hamann, Ute, Lindblom, Annika, Borg, Ake, Piver, M. Steven, Gallion, Holly H., Struewing, Jeffrey P., Whittemore, Alice, Tonin, Patricia, Goldgar, David E., Easton, Douglas F.
Publicado em 1995

Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers

Por Stevens, Kristen N., Wang, Xianshu, Fredericksen, Zachary, Pankratz, Vernon S., Greene, Mark H., Andrulis, Irene L., Thomassen, Mads, Caligo, Maria, Nathanson, Katherine L., Jakubowska, Anna, Osorio, Ana, Hamann, Ute, Godwin, Andrew K., Stoppa-Lyonnet, Dominique, Southey, Melissa, Buys, Saundra S., Singer, Christian F., Hansen, Thomas V.O., Arason, Adalgeir, Offit, Kenneth, Piedmonte, Marion, Montagna, Marco, Imyanitov, Evgeny, Tihomirova, Laima, Sucheston, Lara, Beattie, Mary, Neuhausen, Susan L., Szabo, Csilla I., Simard, Jacques, Spurdle, Amanda B., Healey, Sue, Chen, Xiaoqing, Rebbeck, Timothy R., Easton, Douglas F., Chenevix-Trench, Georgia, Antoniou, Antonis C, Couch, Fergus J.
Publicado em 2012